Imidazopyridines: A novel class of hNav1.7 channel blockers

Bioorganic & Medicinal Chemistry Letters
2008.0

Abstract

A series of imidazopyridines were evaluated as potential sodium channel blockers for the treatment of neuropathic pain. Several members were identified with good hNa(v)1.7 potency and excellent rat pharmacokinetic profiles. Compound 4 had good efficacy (52% and 41% reversal of allodynia at 2 and 4h post-dose, respectively) in the Chung rat spinal nerve ligation (SNL) model of neuropathic pain when dosed orally at 10mg/kg.

Knowledge Graph

Similar Paper

Imidazopyridines: A novel class of hNav1.7 channel blockers
Bioorganic & Medicinal Chemistry Letters 2008.0
Discovery of pyrrolo-benzo-1,4-diazines as potent Nav1.7 sodium channel blockers
Bioorganic & Medicinal Chemistry Letters 2014.0
A novel benzazepinone sodium channel blocker with oral efficacy in a rat model of neuropathic pain
Bioorganic & Medicinal Chemistry Letters 2013.0
Substituted Indazoles as Na<sub>v</sub>1.7 Blockers for the Treatment of Pain
Journal of Medicinal Chemistry 2016.0
3-Oxoisoindoline-1-carboxamides: Potent, State-Dependent Blockers of Voltage-Gated Sodium Channel Na<sub>V</sub>1.7 with Efficacy in Rat Pain Models
Journal of Medicinal Chemistry 2012.0
An imidazole based H-Phe-Phe-NH 2 peptidomimetic with anti-allodynic effect in spared nerve injury mice
Bioorganic &amp; Medicinal Chemistry Letters 2018.0
Structural hybridization of pyrrolidine-based T-type calcium channel inhibitors and exploration of their analgesic effects in a neuropathic pain model
Bioorganic &amp; Medicinal Chemistry Letters 2019.0
2,4(5)-Diarylimidazoles: Synthesis and biological evaluation of a new class of sodium channel blockers against hNav1.2
Bioorganic &amp; Medicinal Chemistry Letters 2008.0
Discovery of Potent, Selective, and State-Dependent Na<sub>V</sub>1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure–Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides
Journal of Medicinal Chemistry 2020.0
Discovery of a biarylamide series of potent, state-dependent NaV1.7 inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2017.0